Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease

OBJECTIVE: The incidence of adverse events in myeloablative transplant protocols is high in refractory Crohn’s disease; this study used low doses of cyclophosphamide. Fourteen patients were submitted to non-myeloablative autologous hematopoietic stem cell transplantation. RESULTS: The average number...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:BMC Res Notes
मुख्य लेखकों: Ruiz, Milton Artur, Kaiser, Roberto Luiz, de Quadros, Luiz Gustavo, Piron-Ruiz, Lilian, Peña-Arciniegas, Tatiana, Faria, Mikaell Alexandre Gouvea, Siqueira, Rubens Camargo, Pirozzi, Flavio Fontes, Kaiser, Fernanda Soubhia Liedtke, Burt, Richard K.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2017
विषय:
Research Note
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5639601/
https://ncbi.nlm.nih.gov/pubmed/28985769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2824-1
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन